|
FY2025
12 months to Dec 27, 2025
|
FY2024
12 months to Dec 28, 2024
|
FY2023
12 months to Dec 30, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 25, 2021
|
|
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net income | |||||
| Depreciation and amortization | |||||
| Gain associated with the Juice Transaction | |||||
| Impairment and other charges | |||||
| Indirect tax impact | |||||
| Product recall-related impact | |||||
| Payments for product recall-related impact | |||||
| Operating lease right-of-use asset amortization | |||||
| Share-based compensation expense | |||||
| Restructuring Charges | |||||
| Cash payments for restructuring charges | |||||
| Pension and retiree medical plan expenses | |||||
| Pension and retiree medical plan contributions | |||||
| Deferred income taxes and other tax charges and credits | |||||
| Tax expense related to the TCJ Act | |||||
| Tax payments related to the TCJ Act | |||||
| Change in assets and liabilities | |||||
| Accounts and notes receivable | |||||
| Inventories | |||||
| Prepaid expenses and other current assets | |||||
| Accounts payable and other current liabilities | |||||
| Income taxes payable | |||||
| Other, net | |||||
| Net Cash Provided by Operating Activities | |||||
| Investing Activities | |||||
| Capital spending | |||||
| Sales of property, plant and equipment | |||||
| Acquisitions, net of cash acquired, investments in noncontrolled affiliates and purchases of intangible and other assets | |||||
| Proceeds associated with the Juice Transaction | |||||
| Divestitures, sales of investments in noncontrolled affiliates and other assets | |||||
| Short-term investments, by original maturity: | |||||
| More than three months - purchases | |||||
| More than three months - maturities | |||||
| More than three months - Sales | |||||
| Three months or less, net | |||||
| Other investing, net | |||||
| Net Cash Used for Investing Activities | |||||
| Financing Activities | |||||
| Proceeds from issuances of long-term debt | |||||
| Payments of long-term debt | |||||
| Debt redemptions | |||||
| Short-term borrowings, by original maturity | |||||
| More than three months - proceeds | |||||
| More than three months - payments | |||||
| Three months or less, net | |||||
| Payments of acquisition-related contingent consideration | |||||
| Cash dividends paid | |||||
| Share repurchases - common | |||||
| Proceeds from exercises of stock options | |||||
| Withholding tax payments on restricted stock units (RSUs) and performance stock units (PSUs) converted | |||||
| Other financing | |||||
| Net Cash Used for Financing Activities | |||||
| Effect of exchange rate changes on cash and cash equivalents and restricted cash | |||||
| Net Increase/(Decrease) in Cash and Cash Equivalents and Restricted Cash | |||||
| Cash and cash equivalents and restricted cash | |||||
| Acquisition and divestiture-related charges | |||||
| Payments for Merger Related Costs | |||||
Loading...